TYSONS CORNER, VA, Aug. 3, 2016 â Siemens has received emergency use authorization from the Food and Drug Administration for the
The Biomedical Advanced Research and Development Authority has awarded Emergent BioSolutions (NYSE: EBS)Â a potential $21.9 million task order to develop
TYSONS CORNER, VA, April 11, 2016 â Leidos (NYSE: LDOS) will work with Immunovaccine to develop a vaccine that aims